Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II)

被引:29
作者
de With, K
Bergner, J
Bühner, R
Dörje, F
Gonnermann, C
Haber, M
Hartmann, M
Rothe, U
Strehl, E
Steib-Bauert, M
Kern, WV
机构
[1] Univ Freiburg Hosp, Ctr Infect Dis & Travel Med, D-79106 Freiburg, Germany
[2] Dresden Univ Hosp, D-01307 Dresden, Germany
[3] Univ Cologne Hosp, D-50931 Cologne, Germany
[4] Univ Erlangen Hosp, Serv Pharm, D-91054 Erlangen, Germany
[5] Ulm Univ Hosp & Med Ctr, D-89070 Ulm, Germany
[6] Saaaarland Univ Hosp Pharm, D-66421 Homburg, Germany
[7] Jena Univ Hosp, D-07747 Jena, Germany
[8] Univ Hosp REgensburg, D-93042 Regensburg, Germany
[9] Univ Hosp Freiburg, Serv Pharm, D-79106 Freiburg, Germany
关键词
hospital antibiotic use; pharmacoepidemiology; nosocomial infection;
D O I
10.1016/j.ijantimicag.2004.03.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In a pilot study we established a hospital antibiotic use database from which estimates for antibiotic consumption in German hospitals (expressed as defined daily doses per 100 patient days, DDD/100) can be retrieved for both benchmarking and antibiotic use and resistance research purposes. Data from eight university hospitals (1998-2000) showed a mean antibiotic use density of 60.1 DDD/100 in the surgical and 79.3 DDD/100 in the medical services. Antibiotic use was higher in the intensive care units (surgery: 146 DDD/100, medicine: 187 DDD/100) than in haematology-oncology services (110.8 DDD/100) or in other surgical (51.6 DDD/100) and medical (66 DDD/100) service areas. There were major differences in the use of specific antibacterial drug classes between service areas. The established database allows detailed analysis in antibacterial drug use and can be linked to bacterial resistance surveillance databases. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 27 条
  • [1] AUCKENTHALER R, 1994, SCHWEIZ ARZTEZTG, V75, P91
  • [2] DANMAP: monitoring antimicrobial resistance in Denmark
    Bager, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (04) : 271 - 274
  • [3] BERZINA S, 2003, CLIN MICROBIOL INFEC, V9, P360
  • [4] Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control
    Bonten, MJM
    Austin, DJ
    Lipsitch, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) : 1739 - 1746
  • [5] CARS O, 2002, REPORT SWEDISH ANTIB, P1
  • [7] Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
    Fridkin, SK
    Steward, CD
    Edwards, JR
    Pryor, ER
    McGowan, JE
    Archibald, LK
    Gaynes, RP
    Tenover, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 245 - 252
  • [8] Increasing prevalence of antimicrobial resistance in intensive care units
    Fridkin, SK
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (04) : N64 - N68
  • [9] The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units
    Fridkin, SK
    Edwards, JR
    Courval, JM
    Hill, H
    Tenover, FC
    Lawton, R
    Gaynes, RP
    McGowan, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) : 175 - 183
  • [10] Glück T, 2000, MED KLIN, V95, P69